All sites C00-96,D32-33,D42-43,D45-47,D76 460 92.1 0.7 3.8 0.8 2.7
Mouth, pharynx C00-14 13 95.2 1.6 1.6 1.6 -
  Lip C00 2 100.0 - - - -
  Tongue C02 3 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 1 25.0 25.0 25.0 25.0 -
  Pharynx C01,C09-14 4 100.0 - - - -
Digestive organs C15-26 92 86.1 1.1 8.2 1.5 3.0
  Oesophagus C15 9 97.9 - - 2.1 -
  Stomach C16 9 97.8 - 2.2 - -
  Small intestine C17 1 100.0 - - - -
  Colon C18 26 95.4 - 1.5 0.8 2.3
  Rectum, rectosigmoid C19-20 17 94.3 - 5.7 - -
  Anus C21 0 100.0 - - - -
  Liver C22 7 90.9 - 3.0 3.0 3.0
  Gallbladder, bile ducts C23-24 2 75.0 - 16.7 8.3 -
  Pancreas C25 20 57.1 5.1 25.5 2.0 10.2
  Other digestive organs C26 1 25.0 - 50.0 25.0 -
Respiratory organs C30-39 55 81.9 0.7 11.2 1.1 5.1
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 3 100.0 - - - -
  Lung, trachea C33-34 51 80.8 0.8 11.8 1.2 5.5
  Mediastinum, pleura C38 1 75.0 - 25.0 - -
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 17 100.0 - - - -
Skin, non-melanoma C44 33 99.4 0.6 - - -
Mesothelioma C45 2 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 100.0 - - - -
Breast C50 1 100.0 - - - -
Male genital organs C60-63 138 99.1 - 0.1 0.1 0.6
  Prostate C61 133 99.1 - 0.2 0.2 0.6
  Testis C62 3 100.0 - - - -
  Other male genital C60,C63 2 100.0 - - - -
Urinary organs C64-68 42 96.7 - 1.0 0.5 1.9
  Kidney C64 16 91.5 - 2.4 1.2 4.9
  Bladder and urinary tract2 C65-68 26 100.0 - - - -
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 9 95.7 - 2.2 - 2.2
Thyroid gland C73 1 100.0 - - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 12 63.9 1.6 21.3 4.9 8.2
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 42 86.6 2.4 - 1.0 10.0
  Hodgkin lymphoma C81 3 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 19 99.0 - - - 1.0
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 4 76.2 - - 4.8 19.0
  Leukaemia C91-95 7 70.6 11.8 - 2.9 14.7
  Myelodysplastic syndromes D46 2 9.1 9.1 - - 81.8
  Myeloproliferaitive neoplasms D45,D47 6 93.8 - - - 6.3
Not included above
  Basal cell carcinoma of the skin 71 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.